Answers are grounded in this paper and cite their sources.
Underlying diabetes mellitus type 2 are considered risk factor for increased coronavirus disease (COVID-19) disease severity and worse outcomes, including higher mortality, respiratory failure, thromboembolic complications.In this regard, it is relevant to study the factors influencing the unfavorable outcomes of the course of Covid-19 in diabetes mellitus type 2. The most important task is to organize the management of diabetes mellitus during the period of coronavirus infection and the choice of safe and effective glucose-lowering therapy. This article analyzes the impact of previous and current glucose-lowering therapy on the outcomes of coronavirus infection in patients with diabetes mellitus type 2 based on published research results
No takes yet. Share an insight, caveat, or question.
Abdrakhmanova et al. (2022) studied this question.
Synapse has enriched 4 related papers. Consider them for comparative context: